Quanterix Corp (QTRX) 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Quanterix Corporation on June 9, 2026. The filing discloses the appointment of a new Chief Financial Officer and Treasurer and provides details regarding the associated employment agreement.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change reported is the appointment of Jason Faessler as Chief Financial Officer and Treasurer, effective June 22, 2026. Mr. Faessler joins from Bruker Corporation, where he served as Senior Vice President of Finance.
Management Commentary and Compensation Details
The Company has entered into an employment agreement with Mr. Faessler dated May 31, 2026. Key terms include:
- Base Salary: $475,000 annualized.
- Sign-on Bonus: $200,000 cash.
- Performance Bonus: Target of up to 50% of base salary.
- Equity Award: Restricted Stock Units (RSUs) equivalent to 0.30% of outstanding common stock on the start date, vesting in four equal annual installments.
- Severance: 12 months of base salary and pro-rated bonus upon termination without Cause or resignation for Good Reason. In the event of a Change-in-Control, unvested equity awards also vest.
Investor Verification Checklist
- Verify the exact number of shares outstanding on June 22, 2026, to calculate the total equity grant value.
- Review the full Employment Agreement (Exhibit 10.1) for specific definitions of "Cause," "Good Reason," and "Change-in-Control."
- Confirm the impact of the $200,000 sign-on bonus on the Company's immediate cash flow and expense recognition.
- Assess the strategic fit of Mr. Faessler's background in global FP&A and clinical divisions for Quanterix's growth stage.